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Abstract  
Poor Medication Adherence (MA) remains a major challenge to ensuring good patient health. This 
qualitative study examines health professionals’ and health technology designers’ insights for improving 
this problem using mHealth. We interviewed twenty-three New Zealand health professionals and 
analysed the interviews using content analysis. In this paper, we discuss the four main themes that 
emerged from our analysis: 1) patient characteristics, 2) collaboration among members of the health 
team, 3) medication impact including effectiveness and side effects 4) technology acceptance. We 
present a conceptual model to visually summarise MA issues from healthcare professionals' and 
technology designers’ perspective. 
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1 INTRODUCTION  
Medication adherence (MA) refers to the timely intake of medication by a patient as prescribed by a 
healthcare provider (Lüscher and Vetter 2005). World Health Organisation (WHO) considers MA a 
priority global problem because failure on the part of patients to take medications as prescribed leads to 
out-of-control epidemics that not only affect the individual patient but also disrupt the entire healthcare 
system (Dekoekkoek et al. 2015). Although technology has contributed immensely to the development 
of healthcare systems worldwide, MA remains an unsolved problem (McDaniel and Einstein 2016). A 
significant barrier to effective medical treatment is patients’ failure to adhere to physicians’ 
recommendations. When a healthcare provider prescribes a medication to a patient, it is uncertain 
whether the patient will be cured. According to Kvarnstrom et al. (2018), healthcare professionals are 
the primary contributors to improving a patient’s health. mHealth is possibly a strategy that can be 
recommended to non-adherent patients by healthcare professionals or pharmacists when the said 
professionals incorporate it into their practice, which is not the case in New Zealand’s healthcare system.  
The present study aims to explore MA from the perspectives of healthcare professionals and health 
technology designers. The contributions of this study are as follows: 
• It captures healthcare professionals’ understanding of the multifaceted dilemma of MA. 
• It provides insights on how mHealth could be used to improve collaboration among the 
members of healthcare delivery teams and the patient. 
The remainder of this paper is organized as follows. Section 2 presents related work. In Section 3, we 
describe the data-collection methodology and analysis techniques used in this study. Then, in Section 4, 
we explain and discuss our findings and present the output of the analysis conducted in this study in the 
form of a conceptual model. Finally, in Section 5, we describe the strengths and limitations of this study, 
present a few concluding remarks, and chalk out an outline for future work. 
2 RELATED WORK 
For more than four decades, researchers presented techniques to improve MA which consequently had 
significant benefits on patients with long-term illness (Patton 2017). Most of these techniques used 
individual reports of medication taking, wearable sensors, real-time electronic monitoring, pharmacy 
refills, text messaging, and mobile apps (Badawy et al. 2017).  
2.1 Existing Issues of Medication Adherence 
Studies related to MA provide reasons for non-adherence in order to find solutions (Elliott 2013). An 
extended view that takes into account interactions between the patient and the healthcare provider and 
between the patient and the healthcare system will have the ultimate effect on improving adherence 
(Osterberg et al. 2005). Previous studies on MA categorised reasons for non-adherence into five main 
factors: Healthcare system/team factors, which include the source of medications, provider 
communication and access to care. The patient-related factors: which include age and gender. The 
therapy-related factors: include polypharmacy, side effects, duration of therapy, frequency of changes 
and ineffective therapy. The condition-related factors represent the current health status. The social and 
economic factors; covers the cultural side, the cost of medication and health literacy (Osterberg et al. 
2005).  In 2015, almost the same main reasons for non-adherence introduced by Lam and Fresco (2015) 
when conducting their study on MA measures. They included direct measures, like pill count, electronic 
medication packaging devices and indirect measures, like clinician assessments and self-reports. It was 
concluded that a multi-measure approach seems to be the best solution. Gajria et al. (2014) report on 
the discontinuation of medication based on age range. The reasons differed slightly between each age 
group; for example, parents/caregiver’s decision, poor adherence, school factors and misdiagnosis were 
more likely to be factors for children rather than for adults.  
Moreover, the study conducted by Wali and Grindrod (2016) shows that health literacy plays a 
significant role in treatment progress. It was reported that patients with low health literacy are 10 to 18 
times less likely to adhere or correctly identify their medication than those with adequate health literacy 
skills. Some patients have difficulties in understanding health information, forget to take medications, 
want more instructions and information on side effects, have a poor understanding of medication 
information and how to make suitable health decisions; in these cases, tailored medication counselling 
is required to meet their basic needs (Ngoh 2009). In some disease conditions, more than 40% of 
patients sustain significant risks by misunderstanding, forgetting or ignoring healthcare advice (Andrew 
Martin et al. 2016). 
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2.2 Existing mHealth Work to Improve MA 
Studies on mobile phone technology interventions to improve MA categorised the interventions into 
three main categories: voice calls, mobile phone text messaging and mobile phone apps. As per the 
systematic review by Anglada-Martinez et al. (2015), most studies demonstrated improved clinical 
outcomes. Moreover, in the integrative review conducted by Park et al., 22 out of 28 studies validated 
the effectiveness of mobile technology in improving clinical outcomes due to improved MA (Park et al. 
2016). 
2.2.1 Voice Call Interventions to Improve MA 
In a review study of Griffiths et al. (2017), patients received telephone calls after the first, second and 
fourth week of the intervention. Voice calls are used in many MA interventional research to follow-up 
and collect feedback during or after the study ends according to the systematic review conducted by 
Rootes-Murday et al. (2017). However, it was difficult to conclude that it is the best solution over a short 
period. Additionally, voice calls are less feasible compared with text messaging and mobile apps. 
2.2.2 Text Message Interventions to Improve MA 
In a study conducted by Dekoekkoek et al. (2015), 9 out of 13 studies showed adherence rates improved 
by 15% to 18% when using text messages to promote MA. Text messages that were standardised, tailored, 
one- or two-way and timed either daily, weekly or monthly according to the medication regimen showed 
improvement in MA. The authors set guidelines for the future development of text messages and 
recommended translating evidence into practice through implementation. 
Kannisto KA et al. explored patients’ feedback on receiving SMS reminders on antipsychotic medication 
for 12 months. The participants filled a survey which was designed using existing literature on service 
experience and technology acceptance model. Their study concluded the use of simple existing 
technology such as mobile phones and SMS was endorsed by the participants (Kannisto et al. 2014). In 
the paper, Mobile Phone Interventions for the Secondary Prevention of Cardiovascular Disease, 
conducted by Park et al. ( 2016), the majority of the studies had a 79% effectiveness in improved 
outcomes with the use of text messaging and mobile app reminders. However, the reasons for 21% 
failure were not justified or reported. In a three-month study of asthma treatment, the patients were 
randomised to receive or not receive a daily SMS reminder. The study concluded that the mean 
adherence rate increased from 77.9% to 81.5% for the ones who received SMS reminders. However, they 
did not mention any reason for the 18.5% who showed no improvement, and it is unclear if they were 
not adherent, or they did adhere to the medication, but their health did not improve, or they did not 
receive the SMS (Strandbygaard et al. 2010). This leads us to highlight the importance of smartphone 
apps that evolve much faster than other techniques, and, because apps can be validated and updated 
over a specific period, more features can be added to the initial version. 
2.2.3 Mobile App Interventions to Improve MA 
Currently, there are approximately 2.53 billion smartphone users worldwide, including healthcare 
providers, consumers and patients who can potentially use healthcare apps (Statista 2018). Kennely et 
al. (2016) argue that mobile health technology could save the healthcare system approximately 290 
billion US dollars in medication management costs. However, the vast increase in the number of 
mHealth apps worries healthcare providers, due to risks which may be a violation of users’ online 
privacy, or offer dubious medical information and advice (Aitkin et al. 2017). Several studies have 
presented the beneficial effects of mobile apps in terms of patient compliance and quality of life in 
various disease situations (Hamine et al. 2015). Few studies looked at smartphone apps, such as 
MedLink, which examined the feasibility and acceptance but not the effectiveness of the app, MA 
detected was 82%. Participants showed a significant decrease in depressive symptoms on health 
questionnaire and the Quick Inventory of Depressive Symptomatology and their challenge was further 
evaluation of MedLink through a randomised controlled trial to evaluate the efficacy of the improvement 
of processes of care, symptoms of depression and patient adherence (Rootes-Murdy et al. 2017). 
Moreover, the study “Don't Forget Your Pill! (Stawarz et al. 2014) aimed to report the findings of a 
functionality review of 229 medication reminder apps, highlighted the gap between the theory and 
practice. It also demonstrated how apps could be implemented to move from passive alerts to a smarter 
memory and routine assistant. They concluded that regardless of the type, functionality or complexity 
of the app, the snooze option is rarely available. Moreover, taking medication is a routine task, and the 
functions that explicitly support routine-based reminders are not available. Their challenge was that the 
functionality of existing apps’ lack of support for personalised daily routines, to add notifications, and 
to allow post-completion checks. Despite the vast positive results on mobile app interventions’ 
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contribution to solving the MA dilemma, gaps remain in understanding how these solutions may fail 
when applied in a clinical setting.  
3 METHODOLOGY 
We used online and face-to-face semi-structured interviews with healthcare professionals and health 
technology designers. The purpose was to gain a deeper understanding of their perceptions towards MA 
and the approaches they might have used in the past. The interviews were audio-recorded. All recordings 
transcribed and deconstructed for analysis. In this study, we used semi-structured questions to allow 
the participants to approach the subject from their experience, as listed below: 
• How can you describe MA? 
• What do you think about the way MA is promoted today? 
• Have you been involved in any MA initiatives? 
• What do you think about technology-assisted MA? 
• What benefits could we achieve by introducing solutions for MA? 
• What challenges do we anticipate? 
• What implementation implications do you envisage? 
• Would we require wider support to make similar solutions successful? 
We used purposeful sampling to select participants (Martin 1996). The participants were selected 
through LinkedIn based on the following criteria; work in New Zealand and has the role of a Healthcare 
Professional or Technology Designer, or Pharmacist or Nurse or a researcher in the field of health 
informatics. In the recruitment process, experience and workplace were considered. The participants at 
the time of the study were working in Hospitals, Pharmacists, GP Clinics, Tech industry and Universities 
in New Zealand researching in Health IT domain. Recruitment and data collection continued until when 
it became clear that there was no new information provided or repetition of information from several 
participants, which means the saturation of data has been reached for this topic. Particular attention 
was paid to the data contradicting with theoretical relationships, to avoid the research bias from the 
literature review.  
The Grounded Theory (GT) to analyse the data is utilised. GT is a qualitative methodology; defined as 
‘the discovery of theory from data’, which is systematically obtained and analysed (Urquhart 2013). GT 
can utilise in-depth interviews as one of its data collection methods. GT has both the process of category 
identification and integration (as a method) and its product (as theory). GT as a method provides us 
with guidelines on how to make links between categories and how to establish relationships between 
them (Strauss and Corbin 1998). Hence, it provides an explanatory framework to gain a deeper 
understanding of the phenomenon of the study. GT as a theory is the end-product of this process. Coding 
is an essential step in GT, Strauss states, “The excellence of the research rests in large part on the 
excellence of the coding” (Strauss and Corbin 1998). Grounded theory method implies data coding, “a 
bottom-up technique in relation to the data, and begins at the word or sentence level” (Claser and 
Strauss 1967). 
4 FINDINGS AND DISCUSSION 
Twenty-three experts from a multidisciplinary background team (from the healthcare sector (17), health 
technology design (4) industry and health informatics researcher (1)) participated in this study. The area 
of expertise of the participants can be expected to have a different perception of MA and the approach 
of technology-assisted MA.  
Several initial codes were identified for each interview question during the analysis phase. As more codes 
emerged, the data were clustered into focused codes, which led to more generalised categories. With 
theory building in mind, the categories were organised as themes. From the main themes, the theoretical 
relationships were mapped out. Attention was paid to the data contradicting with theoretical 
relationships, to avoid research bias from the literature review.  
For the sake of simplicity, we have presented the summary of the quantified codes and categories as 
shown in Table 1. These categories are Patient Characteristics, Collaboration between the health team, 
placing the patient at the centre of the health circle, Medication Impact effectiveness and side effect, and 
the Technology Acceptance.  
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Patient education (24) 
















Simplicity of use (36) 
Time constraint (146) 
Total  65 88 123 233 
Table 1. Quantified categories and focused code  
This research focused on the relationship between the themes as a process that eventually affects 
patients’ health outcome positively. No single model fitted our study plan. Therefore, a conceptual model 
was developed, integrating the themes from the preliminary data with the existing MA models (Sirur et 
al. 2009; Timmerman et al. 2017), as shown in Figure 1. 
 
Figure 1: Medication adherence conceptual model 
We have presented the findings in this section along with the discussion according to the themes laid 
out by the research question. The five themes were described and supported with illustrative quotations 
of the interview extracts as direct quotes from the transcribed interviews. 
4.1 Patient Characteristics 
The first theme is the patient characteristics which is related directly to the patient or within his ability, 
and it involves patient education, patient attitude, adoption, affordability and patients’ demographics in 
terms of age and ethnicity only. Studies proved significant disparities in the intensity of adherence to 
medication between women and men and their likelihood of receiving guideline-based therapy for using 
their medication (Manteuffel et al. 2014). However, unexpectedly the gender factor is unstated in the 
interviews by any of the participants. Moreover, the healthcare consultants regarded involving the ability 
of the patient, which can be the physical ability or the mental ability to comply with medication is 
extremely important and contributes to MA. Therefore, if technology will allow continuous monitoring 
or feedback, they can achieve better health outcomes, better patient experience, a better quality of life 
and minimising side effects. 
Examples of the interview extracts are provided in order to characterise the nature of the data used in 
this study. 
• “I define adherence as more of an understanding of why they have to take their medication 
regularly.” 
• “once they are educated and they know the importance of it they will continue to take it.” 
• “A lot of patients are defiant and don’t want to admit that they have a problem.“ 
• “the only challenge would be to educate patient first.” 
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• “some people might be on an anti-depressant and they want to take a herbal remedy and they 
shouldn’t really. Adherence is a holistic thing, it’s not just about when you take your medicine, 
it is about understanding. So I think if there’s a feature on there, which will give you some more 
information about what you can take, is this safe to take? Because a lot of people now they buy 
things online, a lot of people don’t actually come into the pharmacy, they’ll buy natural 
supplements on-line. “ 
• “understand how to adapt medications to their own circumstances” 
4.2 Collaboration 
This category represents what is related to involving patients, health team and family members and 
carers in the healthcare circle considering the patient at the centre of the circle with the privilege of 
empowerment to take charge of his treatment. Health data sharing as a centralised database to eliminate 
errors of multiple data sources. And data collection where the patient can feed some information back 
to specific members of the health circle to support him during the MA plan and process. A related study 
found that patient-driven healthcare can be characterized as having an increased level of information 
flow, customization, collaboration and responsibility-taking, as well as predictive and preventive facets 
(Swan 2009). Examples of the interview extracts are provided in order to characterise the nature of the 
data used in this study: 
• “I think the first thing is a better communication” 
• “Know the time of meds missed and solve that particular time frame” 
• “help us understand and detect patterns of how the patients are taking their medication” 
• “Patients don’t remember which medication they are taking when they are admitted to hospital” 
• “first any tool has to have a pharmacist involvement and first of all find out why, and what their 
beliefs are. Then, put the right tool in place.” 
• “I definitely think clinicians should be involved, they just need to know if something is wrong 
will make a note in the system… it’s all about avoiding re-hospitalisation. 
4.3 Medication Impact 
This category represents what is related to medication impact or medication use: medication literacy, 
medication effect and patient experience with medication. According to Health Consultants, the 
medication regimen is complex, and advanced interventions are needed to support patients with their 
medication. However, they were certain that results depend on lifestyle when it comes to young people, 
as the age factor contributes heavily to adherence. 
Examples of the interview extracts are provided in order to characterise the nature of the data used in 
this study. 
• “where people with mental health clients, medication adherence, or medication compliance is 
seen as a requirement rather than part of their health plan.” 
• “There’s probably not as much focus on specifically around taking them the right way or at the 
right time.” 
• “it’s about reducing the number of meds… That’s called medicine therapy assessment.” 
• “it’s still not going to work on the person that doesn’t want to take their medicine for a certain 
reason.” 
Adherence is challenging, especially with medications that have substantial side effects and potentially 
used by very young or elderly populations. According to the GPs hospitals, readmissions relates directly 
or indirectly to MA.  
4.4 Use of Technology 
This category covers the patients and healthcare team use of technology, which represents what is 
related to accessibility in terms of being able to access it easily by all the circle members and compatible 
with the available systems used, also by reaching the right people who want to be part of the process.  
Also, there is simplicity, so the technology needs to be simple to use, acceptable by the end-user. Then, 
there is the time constraint which is part of any software development process or any new project and 
the treatment time, which also affects the results of the technology use or the treatment outcome. 
Examples of the interview extracts are provided to characterise the nature of the data used in this study. 
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• “People who have problems remembering their medication, they use an intervention to texting 
and phone calls to remind them about their medication.” 
• “it’s about reducing the number of meds… That’s called medicine therapy assessment” 
• “The most beneficial thing about introducing this is to give an idea of the patient’s actual 
medication taking history.” 
• “I would say that the app itself serves as a measure of motivation and encouragement, so person- 
ally I would say they’d be two different approaches, though the idea that the app is one strategy 
and then family and friends is another one.” 
• “Nowadays everyone is using phones and even in the elderly population are but it’s a matter of 
them being able to access it… so if it’s very complex it might not be worthwhile and it might not 
actually do anything.” 
• “The pharmacy, you sign up, and they can all see if the patient has been double dipping in other 
pharmacies “ 
Therefore, they considered merging technology and healthcare is the solution that can help the 
population, and it needs to be implemented within the health system to improve the process and lower 
cost.  
Having a technology-driven solution will be valuable to the healthcare organisation, to the patient, to 
the caregivers, family and community. A simple app that does the medication reminding might work, or 
SMS messages might also be good because they do not need to be downloaded. But with the app, it will 
include more functionality like acknowledgement and history of taking medication. However, it has to 
be simple to use and continuously improved to have a nice-looking interface that people will accept 
avoiding a strong clinical background in terms of health research.  
5 CONCLUSION AND FUTURE WORK 
In this paper, we developed a conceptual model based on healthcare professionals’ and health 
technology designers’ insights into poor MA and a method for improving MA by using mHealth. The 23 
participants interviewed in this study were concerned about poor MA, which, according to them, 
prevents patients from fully benefiting from their prescribed medications.  
The healthcare professionals expressed concerns about the consequences of not taking medication as 
prescribed and the resulting risk of failing to achieve the expected improvements in health outcomes 
within a specific period. The pharmacists stressed on having patients fill in prescriptions on time and 
prevent wastage of medication through medication literacy. The technology designers and researchers 
were interested in utilising technology to solve some of the problems related to time constraints, human 
errors, and accessibility. 
The interviewees suggested many ideas to mitigate the problems caused by a lack of MA. A few key 
insights include the patients’ ability to engage in their courses of treatment, collaboration among 
members of healthcare teams, placement of patients at the centre of the healthcare circle, explanation 
of the potential effectiveness and side effects of prescribed medications, and acceptance and simplicity 
of technology usage. 
The strength of this study was our comprehensive sampling of the participants, who included healthcare 
professionals in direct contact with patients and health technology designers experienced in developing 
technological tools for patients. The interviews were analysed to define the underlying themes and 
subthemes. Moreover, we continued participant recruitment until the data were saturated. These 
findings will contribute to improving our understanding of the complexity of MA. The limitation of this 
study is the lack of patients’ insights on dealing with adherence issues. In the future, MA can be 
investigated from the perspective of patients. Moreover, mHealth can be developed to address concerns 
pertaining to MA through improved and secure communication between patients and healthcare teams.  
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